Last reviewed · How we verify
NCT06238011: CABG
Dexmedetomidine vs Control on Attenuation Hemodynamic Response to Noxious Stimuli in CABG Surgical Patients
NA trial testing Dexmedetomidine in CABG in 60 participants. Status unknown.
30 April 2024
Quick facts
| Lead sponsor | Sawanpracharak hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 28 February 2024 |
| Primary completion | 30 April 2024 |
| Estimated completion | 10 May 2024 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Dexmedetomidine (dexmedetomidine) — full drug profile →
- Normal saline
Conditions studied
- CABG — all drugs for CABG →
Sponsor
Sawanpracharak hospital
Who can join
Adults 40 to 75, any sex, with CABG. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aim to study efficacy of dexmedetomidine to attenuate hemodynamic response to intubation, skin incision, sternotomy and aortic cannulation
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06238011
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dexmedetomidine
Trials testing the same drug.
- NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
- NCT07398066 — DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) · NA · not yet recruiting
- NCT07377981 — An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp · Phase 4 · not yet recruiting
- NCT07306702 — Dexmedetomidine-Enhanced PCIA After Lobectomy in Nicotine-Dependent Patients · Phase 4 · withdrawn
- NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
Other recruiting trials for CABG
Currently open trials in the same condition.
- NCT07060937 — Clinimetric Properties of Performance Based Functional Outcome Measure After (CABG) Surgery · NA · recruiting
- NCT07331558 — Multimodal VR Rehabilitation for Cardiorespiratory Fitness in CABG Phase II · NA · recruiting
- NCT07451522 — Comparative Analysis of Analgesic Approaches in the Early Period After CABG · NA · recruiting
- NCT07096973 — Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery · recruiting
- NCT06602336 — A Single Centre Study Comparing Continuous Interstitial Fluid Lactate Detection to Standard Measurements of Lactate in P · NA · recruiting
Other Sawanpracharak hospital trials
Trials by the same sponsor.
- NCT06185933 — Lidocaine Spray vs Viscous Lidocaine Solution Plus Lidocaine Spray in Patients Undergoing Non-Sedated EGD · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06238011 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sawanpracharak hospital
- Last refreshed: 5 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06238011.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing